Glyceraldehyde 3-Phosphate Dehydrogenase | | Target | Target | C1orf41 | | | | | | |
Shock | | Disease | Target | C1orf41 | | | | | | |
BNP | | Target | Target | BNP/NPPB | | | | | | |
Diabetes | | Disease | Target | BNP/NPPB | | | | | | |
Azithromycin (Zithromax)- FDA | | Drug | Drug | Azithromycin (Zmax)- FDA | | | | | | |
Sinusitis | | Disease | Drug | Azithromycin (Zmax)- FDA | | | | | | |
Pneumonia | | Disease | Drug | Azithromycin (Zmax)- FDA | | | | | | |
Azithromycin (Zithromax)- FDA | | Drug | Drug | Azithromycin (Zithromax Injection)- FDA | | | | | | |
Myeloperoxidase | | Target | Drug | Azithromycin (Zithromax Injection)- FDA | | | | | | |
Atacand (Candesartan Cilexetil)- FDA | | Drug | Drug | Atacand HCT (Candesartan Cilexetil-Hydrochlorothiazide)- FDA | | | | | | |
Avastin (Bevacizumab)- FDA | | Drug | Drug | Arzerra (Ofatumumab Injection)- FDA | | | | | | |
Argatroban (Argatroban Injection)- FDA | | Drug | Drug | Argatroban Injection (Argatroban)- FDA | | | | | | |
Alprostadil for Injection (Edex)- FDA | | Drug | Drug | Argatroban Injection (Argatroban)- FDA | | | | | | |
Thromboembolism | | Disease | Drug | Argatroban Injection (Argatroban)- FDA | | | | | | |
Platelet Aggregation | | Disease | Drug | Argatroban Injection (Argatroban)- FDA | | | | | | |
Hemorrhage | | Disease | Drug | Argatroban Injection (Argatroban)- FDA | | | | | | |
Stroke | | Disease | Drug | Argatroban Injection (Argatroban)- FDA | | | | | | |
Alprostadil for Injection (Edex)- FDA | | Drug | Drug | Argatroban (Argatroban Injection)- FDA | | | | | | |
Thromboembolism | | Disease | Drug | Argatroban (Argatroban Injection)- FDA | | | | | | |
Platelet Aggregation | | Disease | Drug | Argatroban (Argatroban Injection)- FDA | | | | | | |